Phase I Trial Study of Gemcitabine and Docetaxel With Radiation in Adult Patients With High Grade and Greater Than 5 cm Soft Tissue Sarcoma of the Extremities
Latest Information Update: 24 Mar 2025
At a glance
- Drugs Docetaxel (Primary) ; Gemcitabine (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions
Most Recent Events
- 19 Mar 2025 Status changed from suspended to recruiting.
- 29 Oct 2024 Planned End Date changed from 1 Sep 2024 to 1 Sep 2025.
- 29 Oct 2024 Planned primary completion date changed from 1 Sep 2024 to 1 Sep 2025.